Latest Platform Growth News

Aspermont Limited has completed its Share Purchase Plan and shortfall placement, raising over A$1 million to fund its digital transformation and AI-driven services expansion.

Hiremii Group has successfully raised $650,000 through an oversubscribed placement, underscoring strong investor confidence as it pushes forward with commercialising its AI-driven recruitment platform.

SiteMinder's 2025 Investor Day presentation highlights its Smart Platform's progress, AI-driven hotel revenue tools, and reiterates a strong FY26 outlook with ambitions for accelerated growth.

Aspermont Limited has raised an additional $891,210 through its Share Purchase Plan, complementing a recent $1.75 million institutional placement. This capital injection supports the company’s strategic pivot towards data-driven mining intelligence and AI-powered services.

Osteopore Limited has established OsteoRx, a new special purpose vehicle, with an initial AUD 0.5 million investment to accelerate breakthroughs in cellular regenerative medicine. This strategic move integrates a controlling stake in US-based RxCell Inc, expanding Osteopore’s footprint in the fast-growing stem cell market.

Butn Limited has reported record revenue growth and its first positive operating cash flow for FY25, alongside securing a substantial $100 million funding facility to fuel future expansion.

Vitura Health Limited has announced its third fully franked dividend of 0.2 cents per share following a profitable FY2025, reinforcing its unique position in the medicinal cannabis sector. Shareholders are invited to participate in a discounted Dividend Reinvestment Plan.

Vitura Health reported a modest revenue increase to $124 million for FY2025, while net profit dipped 5.35% due to margin pressures and investment in new platforms. The company declared a fully franked dividend and highlighted growth in telehealth and medical services.

Xamble Group Limited (ASX, XGL) has announced a pro-rata renounceable entitlement offer to raise up to A$1.36 million, including free attaching options exercisable until 2028. The offer is partially underwritten by Eli Capital Pty Limited and aims to accelerate platform growth and technology development.

Pharmx Technologies Limited reported a 13% increase in revenue for FY25, driven by expanded supplier-pharmacy connections and Marketplace platform growth, while profit before tax declined due to significant investments in new technology platforms.

Felix Group Holdings reports a solid 22% increase in FY25 sales revenue and a notable 32% improvement in adjusted EBITDA loss, driven by strong enterprise platform sales and new customer wins.

HUB24 Limited has reported a standout FY25 with robust revenue growth, record net inflows, and a significant dividend increase, reinforcing its leadership in Australia's wealth management platform sector.